C16orf54 and glioblastoma: The analysis of C16orf54 expression and tumour stemness indicators, DNAss and RNAss, suggested that C16orf54 expression was substantially negatively correlated with DNAss in 15 tumour types (Figure 8(c)), including THYM, GBM, and LUSC; significantly positively correlated with DNAss in 7 tumour types, including LGG, KIRP, and THCA; significantly negatively correlated with RNAss in 30 tumour types (Figure 8(d)), including GBM, LGG, CESC, and LUAD; and significantly positively correlated with RNAss in THYM.